Diabetes Research and Clinical Practice · Nov 17, 2026

Associations of the inflammation burden index and the albumin-total bilirubin score with the risk of death in stages 0-3 of cardiovascular-renal-metabolic syndrome: a prospective cohort study based on NHANES

By Yang Y, Wang X, Li R et al.

AIMS: This paper sought to determine the isolated and joint links of the inflammatory burden index (IBI) and the albumin-bilirubin score (ALBI) with all-cause mortality (ACM) and cardiovascular mortality(CM) in Cardiovascular-Kidney-Metabolic Syndrome (CKM) 0-3 patients. METHODS: We included 8,081 participants with CKD 0-3 from NHANES 2005-2010 and 2015-2018. Weighted Cox regression models and Restricted cubic splines (RCS) were constructed to determine the links of IBI, ALBI, and combined IBI-ALBI with ACM and CM. Kaplan-Meier curves were plotted to compare mortality. RESULTS: IBI (ACM: HR 1.092, 95%CI 1.013-1.176; CM: HR 1.184, 95%CI 1.014-1.384) and ALBI (ACM: HR 2.067, 95%CI: 1.418-3.014; CM: HR 2.318, 95%CI 1.082-4.968) were each significantly associated with mortality in CKM 0-3 patients. Compared with the low IBI + low ALBI group, the high IBI + high ALBI group had a substantially elevated mortality risk (ACM: HR 1.614, 95%CI 1.302-2.000; CM: HR 1.734, 95%CI 1.090-2.760). The high IBI + high ALBI group exhibited the lowest survival rate (log-rank P < 0.001). CONCLUSION: In CKM 0-3 patients, IBI and ALBI have individual effects on mortality and exert a joint association. Combining IBI and ALBI may help identify high-risk groups and inform timely intervention.

doi.org/10.1016/j.diabres.2026.113673PubMed 43044769Biomarkers

AgingResearch.News